DE60311000D1 - Indolderivate und deren verwendung als 5-ht liganden - Google Patents

Indolderivate und deren verwendung als 5-ht liganden

Info

Publication number
DE60311000D1
DE60311000D1 DE60311000T DE60311000T DE60311000D1 DE 60311000 D1 DE60311000 D1 DE 60311000D1 DE 60311000 T DE60311000 T DE 60311000T DE 60311000 T DE60311000 T DE 60311000T DE 60311000 D1 DE60311000 D1 DE 60311000D1
Authority
DE
Germany
Prior art keywords
derivatives
indoind
ligands
formula
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60311000T
Other languages
English (en)
Other versions
DE60311000T2 (de
Inventor
Guenter Hoelzemann
Helene Crassier
Henning Boettcher
Timo Heinrich
Kai Schiemann
Joachim Leibrock
Amsterdam Christoph Van
Gerd Bartoszyk
Christoph Seyfried
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of DE60311000D1 publication Critical patent/DE60311000D1/de
Application granted granted Critical
Publication of DE60311000T2 publication Critical patent/DE60311000T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
DE60311000T 2002-12-10 2003-11-17 Indolderivate und deren verwendung als 5-ht liganden Expired - Lifetime DE60311000T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027483 2002-12-10
EP02027483 2002-12-10
PCT/EP2003/012810 WO2004052886A1 (en) 2002-12-10 2003-11-17 Indol derivatives and their use as 5-ht ligands

Publications (2)

Publication Number Publication Date
DE60311000D1 true DE60311000D1 (de) 2007-02-15
DE60311000T2 DE60311000T2 (de) 2007-10-04

Family

ID=32479712

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60311000T Expired - Lifetime DE60311000T2 (de) 2002-12-10 2003-11-17 Indolderivate und deren verwendung als 5-ht liganden

Country Status (15)

Country Link
US (1) US7482465B2 (de)
EP (1) EP1569930B1 (de)
JP (1) JP4563817B2 (de)
KR (1) KR20050085472A (de)
CN (1) CN1723209A (de)
AT (1) ATE350381T1 (de)
AU (1) AU2003288077B2 (de)
BR (1) BR0317126A (de)
CA (1) CA2509225C (de)
DE (1) DE60311000T2 (de)
ES (1) ES2279976T3 (de)
MX (1) MXPA05006076A (de)
PL (1) PL375350A1 (de)
WO (1) WO2004052886A1 (de)
ZA (1) ZA200505491B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7371769B2 (en) 2004-12-07 2008-05-13 Solvay Pharmaceuticals B.V. Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
US20070072870A2 (en) 2004-12-08 2007-03-29 Solvay Pharmeceuticals B.V. Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
RU2007125660A (ru) * 2004-12-08 2009-01-20 Солвей Фармасьютикалс Б.В. (Nl) Фенилпиперазиновые производные с сочетанием свойств неполного агонизма к рецепторам дофамина-d2 и ингибирования повторного поглощения серотонина
WO2013063492A1 (en) * 2011-10-28 2013-05-02 Board Of Regents, The University Of Texas System Novel compositions and methods for treating cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
ATE144773T1 (de) * 1993-04-22 1996-11-15 Pfizer Res & Dev Indol-derivate als 5-ht1-ähnliche antagonisten zur behandlung von migräne
US6150533A (en) * 1998-04-08 2000-11-21 American Home Products Corp. N-aryloxyethyl-indoly-alkylamines for the treatment of depression
GB9903784D0 (en) 1999-02-18 1999-04-14 Lilly Co Eli Pharmaceutical compounds

Also Published As

Publication number Publication date
JP2006510641A (ja) 2006-03-30
EP1569930A1 (de) 2005-09-07
BR0317126A (pt) 2005-10-25
KR20050085472A (ko) 2005-08-29
AU2003288077A1 (en) 2004-06-30
CA2509225A1 (en) 2004-06-24
AU2003288077B2 (en) 2010-05-27
US7482465B2 (en) 2009-01-27
ZA200505491B (en) 2006-05-31
ATE350381T1 (de) 2007-01-15
PL375350A1 (en) 2005-11-28
CN1723209A (zh) 2006-01-18
JP4563817B2 (ja) 2010-10-13
DE60311000T2 (de) 2007-10-04
CA2509225C (en) 2011-09-20
ES2279976T3 (es) 2007-09-01
US20060116405A1 (en) 2006-06-01
EP1569930B1 (de) 2007-01-03
MXPA05006076A (es) 2005-08-16
WO2004052886A1 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
DE60310576D1 (en) 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
DE69910831D1 (de) Epothilonderivate und ihre verwendung als antitumormittel
ATE360627T1 (de) Pyrrolidindion-substituierte piperidin- phthalazone als pde4-inhibitoren
ATE353217T1 (de) 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
MXPA05010652A (es) Pirazoles sustituidos.
ATE433962T1 (de) Piperazinylpyrazinverbindungen als antagonisten des serotonin-5-ht2-rezeptors
ATE449069T1 (de) Aminopropanolderivate
DE602005007064D1 (de) Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
ATE517623T1 (de) Verwendung von methylphenidat-derivaten
MXPA05010651A (es) Compuestos de pirazol.
ATE355265T1 (de) Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren
MXPA06000038A (es) Pirimidinas 2-sustituidas.
MXPA05010650A (es) Pirazoles sustituidos.
EA200600601A1 (ru) Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы
DE60311000D1 (de) Indolderivate und deren verwendung als 5-ht liganden
ATE390427T1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
ATE508130T1 (de) 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren
DE502004009016D1 (de) Verwendung von chinaldin-und naphthalinderivaten als kristallisationsmodifikatoren
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe
DE602004017175D1 (de) Diphenylurea-derivative und ihre verwendung als chloridkanalblocker
ATE398617T1 (de) Imidazoä4,5-büpyridinderivate als inhibitoren der induzierbaren no-synthase
ATE374778T1 (de) Organosiliziumverbindungen und deren verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition